We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+1.63%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.4B
AUM Growth
-$121M
(-8%)
Cap. Flow
-$42.7M
Cap. Flow
% of AUM
-3.06%
Top 10 Holdings %
Top 10 Hldgs %
47.37%
Holding
90
New
7
Increased
27
Reduced
20
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$26M |
| 2 |
Keros Therapeutics
KROS
|
+$18.9M |
| 3 |
BLU
BELLUS Health Inc.
BLU
|
+$15.4M |
| 4 |
BCYC
Bicycle Therapeutics
BCYC
|
+$14.8M |
| 5 |
FNA
Paragon 28, Inc.
FNA
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aldeyra Therapeutics
ALDX
|
+$26.2M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$25.7M |
| 3 |
YMAB
Y-mAbs Therapeutics
YMAB
|
+$16.5M |
| 4 |
Insmed
INSM
|
+$15.1M |
| 5 |
OptimizeRx
OPRX
|
+$14.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 84.7% |
| 2 | Communication Services | 5.48% |
| 3 | Energy | 0.15% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Insmed
INSM
$21.4B
| $19M | 1.36% |
698,369
-528,914
| -43% | -$15.1M |
|
|
BLU
27
DELISTED
BELLUS Health Inc.
BLU
| $18.7M | 1.34% |
+2,326,528
| New | +$15.4M |
|
28
KORU Medical Systems
KRMD
$189M
| $16.5M | 1.18% |
5,514,106
+105,680
| +2% | +$324K |
|
29
SI-BONE Inc
SIBN
$788M
| $16M | 1.15% |
720,243
+14,561
| +2% | +$313K |
|
30
Teva Pharmaceuticals
TEVA
$40.8B
| $15.2M | 1.09% |
1,897,506
-725,525
| -28% | -$6.55M |
|
31
OrthoPediatrics
KIDS
$519M
| $14.2M | 1.02% |
237,385
+4,893
| +2% | +$305K |
|
|
FNA
32
DELISTED
Paragon 28, Inc.
FNA
| $12.8M | 0.92% |
+722,841
| New | +$13.9M |
|
33
MaxCyte
MXCT
$112M
| $12.6M | 0.9% |
1,232,277
+237,607
| +24% | +$2.55M |
|
|
PHLT
34
DELISTED
Performant Healthcare Inc
PHLT
| $11.8M | 0.84% |
4,886,173
+448,243
| +10% | +$1.33M |
|
35
BioMarin Pharmaceuticals
BMRN
$11.6B
| $11.3M | 0.81% |
127,785
-48,774
| -28% | -$4.02M |
|
|
ITMR
36
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $11M | 0.79% |
355,410
-307,559
| -46% | -$9.38M |
|
|
NGM
37
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $10.1M | 0.72% |
+570,898
| New | +$11M |
|
38
QuidelOrtho
QDEL
$1.14B
| $10.1M | 0.72% |
74,544
+1,534
| +2% | +$214K |
|
39
Pfizer
PFE
$143B
| $8.53M | 0.61% |
144,497
+136,028
| +1,606% | +$6.74M |
|
|
MRTX
40
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8.07M | 0.58% |
+55,024
| New | +$8.54M |
|
41
Crinetics Pharmaceuticals
CRNX
$8.84B
| $7.75M | 0.56% |
+272,796
| New | +$6.73M |
|
|
AXNX
42
DELISTED
Axonics, Inc. Common Stock
AXNX
| $7.6M | 0.54% |
135,752
-206,073
| -60% | -$12.6M |
|
|
AKU
43
DELISTED
Akumin Inc
AKU
| $6.42M | 0.46% |
3,666,648
+106,737
| +3% | +$197K |
|
44
Genmab
GMAB
$17.7B
| $6.29M | 0.45% |
158,947
-100,044
| -39% | -$4.17M |
|
|
SIEN
45
DELISTED
Sientra, Inc.
SIEN
| $5.9M | 0.42% |
160,835
+3,059
| +2% | +$148K |
|
46
Annexon
ANNX
$834M
| $5.44M | 0.39% |
473,700
-10,073
| -2% | -$163K |
|
47
Pliant Therapeutics
PLRX
$64.4M
| $5.22M | 0.37% |
+386,896
| New | +$6.15M |
|
|
ABCM
48
DELISTED
Abcam PLC
ABCM
| $5.16M | 0.37% |
+219,285
| New | +$4.91M |
|
|
NARI
49
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $4.07M | 0.29% |
44,547
+32,813
| +280% | +$2.81M |
|
50
Maravai LifeSciences
MRVI
$969M
| $4.05M | 0.29% |
96,637
-22,066
| -19% | -$894K |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, First Light Asset Management held 90 positions worth $1.4B, down 8% from $1.52B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
First Light Asset Management withdrew a net $42.7M in Q4 2021, closing 11 positions and reducing 20 holdings. Its most notable exit was Aldeyra Therapeutics, an estimated $26.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 81% a quarter earlier, followed by Communication Services and Energy.
Against the trend, First Light Asset Management opened a new position in BELLUS Health Inc. worth $18.7M.
- First Light Asset Management's largest Q4 2021 buy was BELLUS Health Inc.: 2,326,528 shares worth $18.7M.
- First Light Asset Management added most to AtriCure in Q4 2021, an estimated $26M increase.
- First Light Asset Management's biggest Q4 2021 reduction was Insmed, cutting an estimated $15.1M.
- First Light Asset Management fully exited Aldeyra Therapeutics in Q4 2021, selling an estimated $26.2M.
- First Light Asset Management's ten largest holdings make up 47% of its $1.4B portfolio in Q4 2021.
- First Light Asset Management opened 7 new positions and closed 11 in Q4 2021.
- First Light Asset Management's portfolio value fell 8% quarter-over-quarter to $1.4B.
Based on First Light Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.